latest news releases from the newsroom
BSD Medical Corporation
BSD Medical: NCCN Clinical Practice Guidelines Indicate Significantly Superior Treatment Response When Regional Hyperthermia is Added to Chemotherapy
SALT LAKE CITY, Nov. 24, 2008 (GLOBE NEWSWIRE) -- BSD Medical Corporation (Nasdaq:BSDM) today reported that the National Clinical Practice Guidelines in Oncology for Soft Tissue Sarcoma (V.2.2008) issued by the National Comprehensive Cancer Network (NCCN) include reference to the preliminary results from a 341 patient phase III randomized multi-center clinical trial (EORTC-62961 and NCT00003052) involving the use of regional hyperthermia and chemotherapy with EIA (etoposide, ifosfamide and adriamycin), as compared to EIA alone. This landmark trial was led by the University Medical School of Grosshadern, Munich, Germany, and patients were contributed by Duke University Medical School, Durham, N.C., Charite University Medical School Berlin, Duesseldorf University Medical School, both in Germany, Haukeland University Medical School Bergen, Norway, and Graz University Medical School, Austria, all of which used the BSD 2000 Deep Regional Hyperthermia System manufactured by BSD Medical Corp. The clinical practice guidelines reference the study results from the ACRO 2007 Meeting Abstracts (Journal of Clinical Oncology 2007;25(18 suppl):10009), which reported that after a median follow-up of 24.9 months, disease-free survival for locally-advanced high-risk soft tissue sarcoma patients receiving regional hyperthermia was 31.7 months vs. 6.2 months for those receiving EIA alone, progression-free survival was 84% vs. 64% respectively for extremity sarcomas and 57% vs. 39% for body wall and abdominal sarcomas, and overall response rate was 28.7% for those receiving regional hyperthermia plus EIA vs. 12.6% for those receiving EIA alone.
Dolphin Digital Media, Inc.
Dolphin Digital Media Announces Appointment of Financial Advisor
TORONTO, Nov. 24, 2008 (GLOBE NEWSWIRE) -- Dolphin Digital Media, Inc. (OTCBB:DPDM), a developer of unique social networking websites using state-of-the-art fingerprint identification technology, announced today that it has retained the services of New York City based accounting firm Amper, Politziner & Mattia LLP to act as Financial Advisor while the Company conducts a search for a permanent Chief Financial Officer. Peter R. Bible, Partner-in-Charge of Amper's Public Companies Group, will lead the firm's efforts in connection with this assignment.
University of Oklahoma Deploys InfiniBand Network From QLogic
ALISO VIEJO, Calif., Nov. 24, 2008 (GLOBE NEWSWIRE) -- QLogic Corp. (Nasdaq:QLGC), a leading supplier of high performance network infrastructure solutions, today announced the University of Oklahoma (OU) Supercomputing Center for Education & Research (OSCER) deployed QLogic(r) InfiniBand(r) adapters and switches as part of its newest Linux cluster, known as Sooner. OU researchers will use Sooner to study and model tornadoes, in hopes of improving early warning systems and reducing the financial toll and the number of lives lost to these powerful windstorms.
Search Engine Marketing Professional Organization
SEMPO Kicks Off Strategic Relationship With Special Advertising Promotion
WAKEFIELD, Mass., Nov. 24, 2008 (GLOBE NEWSWIRE) -- The Search Engine Marketing Professional Organization (SEMPO) today announced a strategic marketing relationship, which is being kicked off by a special offer to SEMPO members. Microsoft Advertising is offering a search advertising promotion that provides